Novel B-ring modified combretastatin analogues: Syntheses and antineoplastic activity

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 23, 1998, Pages 3371-3374

  Hatanaka, Toshihiro ^a   Fujita, Koichi ^a   Ohsumi, Koji ^a   Nakagawa, Ryusuke ^a   Fukuda, Yumiko ^a   Nihei, Yukio ^a   Suga, Yasuyo ^a   Akiyama, Yukio ^a   Tsuji, Takashi ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AC 7728; AC 7739; ANTINEOPLASTIC AGENT; COMBRETASTATIN A4; PYRIDONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; DRUG CYTOTOXICITY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; MOUSE; NONHUMAN; PLASMA;

EID: 0032402626     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00622-2     Document Type: Article

References (16)

1. 1. Pettit, G. R.; Singh, S. B.; Hamel, E.; Lin, C. M.; Alberts, D. S.; Garcia-Kendall, D. Experientia 1989, 45, 209-211.
2. 2. McGown, A. T.; Fox, B. W. Cancer Chemother. Pharmacol. 1990, 26, 79-81. El-Zayat, A. A. E.; Degen, D.; Drabek, S.; Clark, G. M.; Pettit, G. R.; Von Hoff, D. D. Anti-Cancer Drugs 1993, 4, 19-25.
3. 2. McGown, A. T.; Fox, B. W. Cancer Chemother. Pharmacol. 1990, 26, 79-81. El-Zayat, A. A. E.; Degen, D.; Drabek, S.; Clark, G. M.; Pettit, G. R.; Von Hoff, D. D. Anti-Cancer Drugs 1993, 4, 19-25.
4. 3. Pettit, G. R.; Temple, C. Jr.; Narayanan, V. L.; Varma, R.; Simpson, M. J.; Boyd, M. R.; Rener, G. A.; Bansal, N. Anti-Cancer Drug Des. 1995, 10, 299-309.
5. 4. Ohsumi, K.; Nakagawa, R.; Fukuda, Y.; Hatanaka, T.; Morinaga, Y.; Nihei, Y.; Ohishi, K.; Suga, Y.; Akiyama, Y.; Tsuji, T. J. Med. Chem. 1998, 41, 3022-3032.
6. 5. Lin, C. M.; Singh, S. B.; Chu, P. S.; Dempcy, R. O.; Schmidt, J. M.; Pettit, G. R.; Hamael, E. Mol. Pharmacol. 1988, 34, 200-208. Cushman, M.; Nagarathnam, D.; Gopal, D.; Chakraborti, A. K.; Lin, C. M.; Hamel, E. J. Med. Chem. 1991, 34, 2579-2588. Cushman, M.; Nagarathnam, D.; Gopal, D.; He, H.-M.; Lin, C. M.; Hamel, E. J. Med. Chem. 1992, 35, 2293-2306.
7. 5. Lin, C. M.; Singh, S. B.; Chu, P. S.; Dempcy, R. O.; Schmidt, J. M.; Pettit, G. R.; Hamael, E. Mol. Pharmacol. 1988, 34, 200-208. Cushman, M.; Nagarathnam, D.; Gopal, D.; Chakraborti, A. K.; Lin, C. M.; Hamel, E. J. Med. Chem. 1991, 34, 2579-2588. Cushman, M.; Nagarathnam, D.; Gopal, D.; He, H.-M.; Lin, C. M.; Hamel, E. J. Med. Chem. 1992, 35, 2293-2306.
8. 5. Lin, C. M.; Singh, S. B.; Chu, P. S.; Dempcy, R. O.; Schmidt, J. M.; Pettit, G. R.; Hamael, E. Mol. Pharmacol. 1988, 34, 200-208. Cushman, M.; Nagarathnam, D.; Gopal, D.; Chakraborti, A. K.; Lin, C. M.; Hamel, E. J. Med. Chem. 1991, 34, 2579-2588. Cushman, M.; Nagarathnam, D.; Gopal, D.; He, H.-M.; Lin, C. M.; Hamel, E. J. Med. Chem. 1992, 35, 2293-2306.
9. 6. B-ring modified combretastatin analogues; Medarde M.; Ramos, A.; Caballero, E.; Pelaez, Lamamie de Clairac, R.; Lopez, J. L.; Gravalos, D. G.; Feliciano, A. S. Eur. J. Med. Chem. 1998, 33, 71-77.
10. 7. Katritzky, A. R.; Fan, W-Q.; Li, Q-L. Tetrahedron Lett. 1987, 28, 1195-1198.
11. 8. Taylor, E. C. Jr.; Crovetti, A. J.; Loux, H. M. J. Am. Chem. Soc. 1955, 77, 5445-5446.
12. 9. Frank, M. H.; Mosher, H. S. J. Org. Chem. 1959, 24, 196-198.
13. 10. Hamel, E.; Lin, C. M. Biochemistry 1984, 23, 4173-4184. Muzaffar, A.; Brossi, A.; Lin, C. M.; Hamel, E.; J. Med. Chem. 1990, 33, 567-571.
14. 10. Hamel, E.; Lin, C. M. Biochemistry 1984, 23, 4173-4184. Muzaffar, A.; Brossi, A.; Lin, C. M.; Hamel, E.; J. Med. Chem. 1990, 33, 567-571.
15. 11. Alley, M. C.; Scudiero, D. A.; Monks, A.; Hursey, M. L.; Czerwinski, M. J.; Fine, D. L.; Abbott, B. J.; Mayo, J. G.; Shoemaker, R. H.; Boyd, M. R. Cancer Res. 1988, 48, 589-601. Mossman, T. J. Immunol. Meth. 1983, 65, 55-63.
16. 11. Alley, M. C.; Scudiero, D. A.; Monks, A.; Hursey, M. L.; Czerwinski, M. J.; Fine, D. L.; Abbott, B. J.; Mayo, J. G.; Shoemaker, R. H.; Boyd, M. R. Cancer Res. 1988, 48, 589-601. Mossman, T. J. Immunol. Meth. 1983, 65, 55-63.